Recent Updates
Recently added Catalysts
ATHE Positive Sentiment Score: 65/100

Notification of Issue, Conversion or Payment up of Unquoted Equity Securities Announcement Summary Entity name ALTERITY THERAPEUTICS LIMITED Date of this announcement Thursday

Key Takeaway: Alterity Therapeutics Limited has announced the issuance of 8 million options under an employee incentive scheme, which are unquoted on the ASX. This issuance is part of a strategy to bolster employee motivation without requiring security holder approval under Listing Rule 7.2. The options have an exercise price of AUD 0.0105 and are set to expire on December 19, 2026. The company continues to expand its incentive offerings aimed at enhancing employee engagement and aligning their interests with company growth.

Market Sentiment Analysis

POSITIVE FACTORS

  • The announcement includes the issuance of 8 million options, which is a sign of growth in the company's staff incentive scheme.
  • The company is engaging in practices that bolster employee motivation and alignment through incentives.
  • The issuance of unquoted securities demonstrates confidence in future company performance.

Full Press Release Details

ALTERITY THERAPEUTICS LIMITED
of this announcement
Thursday December 21, 2023
The +securities the subject of this notification
securities issued under an +employee incentive scheme that are not intended to be quoted on ASX
Total number of +securities to be issued/transferred
ASX +security code Security description Total number of +securities to be issued/transferred Issue date
New class - code to be confirmed Options issued under employee incentive scheme 8,000,00 21/12/2023
Refer to next page for full details of the announcement
ALTERITY THERAPEUTICS LIMITED
We (the entity named above) give notice of the issue, conversion
or payment up of the following unquoted +securities.
1.2 Registered Number Type Registration number
ABN 37080699065
1.4 The announcement is
1.5 Date of this announcement
The +securities the subject of this notification are:
+Other securities issued under an +employee incentive scheme that are not intended to be quoted on ASX
2.2 a This notification
is given in relation to an issue of +securities in a class which is not quoted on ASX and which:
does not have an existing ASX security code ("new class")
ASX +security code +Security description
New class - code to be confirmed Options issued under employee incentive scheme
+Security type ISIN code
Options
Date the +securities the subject of this notification
Will all the +securities issued in this class rank
equally in all respects from their issue date?
Were any of the +securities issued to +key management
personnel (KMP) or an +associate?
Have you received confirmation from ASX that the terms
of the +securities are appropriate and equitable under listing rule 6.1?
Please provide a URL link for a document lodged
with ASX setting out the material terms of the +securities being issued.
+Security currency Exercise price Expiry date
AUD - Australian Dollar AUD 0.01050000 19/12/2026
Details of the existing class of +security that
will be issued upon exercise or conversion of this new class of company option
Please provide a URL link for a document
lodged with ASX detailing the terms of the +employee incentive scheme or a summary of the terms
information the entity wishes to provide about the +securities the subject of this notification
Number of +securities
Following the issue, conversion or payment up of the
+securities the subject of this application, the +securities of the entity will comprise:
(A discrepancy in these figures compared to your own
may be due to a matter of timing if there is more than one application for quotation/issuance currently with ASX for processing.)
Quoted +Securities (Total number of each +class of +securities quoted)
ASX +security code and description Total number of +securities on issue
ATH : ORDINARY FULLY PAID 2,802,360,380
Unquoted +Securities (Total number of each +class of +securities issued but not quoted on ASX)
ASX +security code and description Total number of +securities on issue
ATHAAE : OPTION EXPIRING 29-NOV-2026 EX $0.0375 19,250,000
ATHAAF : OPTION EXPIRING 31-JUL-2024 EX $0.07 12,000,000
ATHAAG : OPTION EXPIRING 29-NOV-2026 EX $0.0238 11,900,000
ATHAAB : OPTION EXPIRING 17-SEP-2025 EX $0.09 35,000,000
ATHAAD : OPTION EXPIRING 06-JAN-2026 EX $0.032 91,392,720
New class - code to be confirmed : Options issued under employee incentive scheme 8,000,000
+securities issued under an exception in Listing Rule 7.2 and therefore the issue did not need any security holder approval under Listing
a Select the number of the applicable exception in Listing Rule 7.2

Frequently Asked Questions

What type of securities were issued by Alterity Therapeutics?

Alterity Therapeutics issued options under an employee incentive scheme.

How many options were issued in this announcement?

A total of 8,000,000 options were issued.

What is the exercise price of the new options?

The exercise price for the new options is AUD 0.0105.

What is the expiry date for the newly issued options?

The newly issued options will expire on December 19, 2026.

Are the issued securities quoted on ASX?

No, the issued securities are not intended to be quoted on ASX.

Last updated: Dec 21, 2023